Cognizant Technology Solutions experienced a robust fourth quarter, surpassing both analyst estimates and its management's guidance.Cognizant Technology Solutions (CTSH 0.07%), a professional services company specializing in consulting and outsourcing, delivered its Q4 2024 results on Feb. 5, 2025. The earnings report revealed notable beats in both revenue and adjusted EPS. Revenue came in at $5.1 billion, surpassing the expected $5.07 billion. Adjusted EPS reached $1.21, exceeding predictions by $0.09. Ove ...

Cognizant Reports Fourth Quarter and Full-Year 2024 Results TEANECK, N.J., February 5, 2025 - Cognizant (Nasdaq: CTSH), one of the world's leading professional services companies, today announced its fourth quarter and full-year 2024 financial results. Exhibit 99.1 Constant currency ("CC") revenue growth, Adjusted Operating Margin, Adjusted Diluted Earnings Per Share ("Adjusted Diluted EPS") and free cash flow are not measures of financial performance prepared in accordance with GAAP. A full reconciliation ...

Fourth quarter revenue of $5.1 billion increased 6.8% year-over-year or 6.7% in constant currency1, at the high end of our guidance range Full-year revenue of $19.7 billion increased 2.0% year-over-year or 1.9% in constant currency Full-year operating margin of 14.7% increased 80 basis points year-over-year; Adjusted Operating Margin1 of 15.3% increased 20 basis points year-over-year Trailing 12-month bookings of $27.1 billion, up 3% year-over-year, driven by 11% year-over-year fourth quarter bookings grow ...

Cognizant Technology Solutions (CTSH) is scheduled to report its fourth-quarter 2024 results on Feb. 05.The Zacks Consensus Estimate for earnings is pegged at $1.13 per share, which has increased by a penny in the past 30 days. This indicates a decline of 4.24% from the figure reported in the year-ago quarter. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Cognizant expects fourth-quarter 2024 revenues between $5 billion and $5.1 billion, indicating growth of 5.1%-7.1% (an increase ...

Wall Street analysts expect Cognizant (CTSH) to post quarterly earnings of $1.13 per share in its upcoming report, which indicates a year-over-year decline of 4.2%. Revenues are expected to be $5.06 billion, up 6.4% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a comp ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Cognizant (CTSH) . This company, which is in the Zacks Business - Software Services industry, shows potential for another earnings beat.This information technology consulting and outsourcing firm has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an ...

Core Insights - Cognizant has announced an expanded agreement with Medidata to enhance support for life sciences clients and improve clinical trial development through AI-powered technologies [1][3] Partnership Details - The renewed multi-year agreement includes a dedicated team of Medidata Platform specialists to assist clients in pharmaceutical, biotech, medical device, and contract research organizations [2] - The collaboration aims to maximize Medidata's value for life sciences clients, focusing on improving user experience and patient outcomes [2][4] Technological Integration - The partnership combines Medidata's advanced AI-driven technologies with Cognizant's industry knowledge to streamline R&D efforts and derive actionable insights from complex data [3] - Solutions such as Medidata Clinical Data Studio, Medidata Health Record Connect, and the myMedidata patient portal are part of the initiative to transform R&D experiences [3] Strategic Goals - The collaboration seeks to unlock the full potential of clients' clinical data and processes, enhancing user satisfaction and enabling faster, better-informed decision-making [4]

Core Insights - Cognizant has expanded its partnership with Gilead Sciences to enhance customer service, employee engagement, and business value through AI-driven solutions [1][3] - The collaboration aims to improve cost leadership and productivity for Gilead while leveraging machine learning and generative AI [1][4] - Cognizant's Neuro AI generative AI platform will be utilized to accelerate value creation and improve operational efficiencies for Gilead [3][4] Company Overview - Cognizant has supported Gilead's global IT infrastructure and digital transformation initiatives over the past decade [2] - Gilead Sciences is a biopharmaceutical company focused on developing innovative medicines for life-threatening diseases, operating in over 35 countries [6] Partnership Goals - The expanded agreement seeks to provide significant cost savings that can be reinvested into Gilead's core life sciences business [3] - Cognizant aims to transform the user experience of IT services with custom-built generative AI solutions [3][4] - The partnership is expected to enhance operational efficiencies through leading-edge automation and managed services frameworks [4]

Core Viewpoint - The market anticipates a year-over-year decline in Cognizant's earnings despite higher revenues, with a focus on how actual results compare to estimates [1][2]. Earnings Expectations - Cognizant is expected to report quarterly earnings of $1.13 per share, reflecting a year-over-year decrease of 4.2% [3]. - Revenue projections stand at $5.07 billion, indicating a 6.5% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.17% over the last 30 days, indicating a bearish sentiment among analysts [4]. - The Most Accurate Estimate for Cognizant is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.09% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likelihood of actual earnings deviating from consensus estimates, with positive readings being more predictive of earnings beats [6][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of delivering a positive surprise [8]. Historical Performance - Cognizant has beaten consensus EPS estimates in the last four quarters, with a notable surprise of +9.65% in the last reported quarter [12][13]. Conclusion - Cognizant does not currently appear to be a strong candidate for an earnings beat, and investors should consider other factors when evaluating the stock ahead of its earnings release [16].

Core Insights - McDonald's Corporation (MCD) has extended its partnership with Cognizant Technology Solutions Corporation (CTSH) for several years, building on their collaboration since 2017, focusing on technological excellence and innovative solutions in the restaurant industry [1][2] Partnership Details - The renewed agreement allows Cognizant to continue supporting McDonald's in key enterprise areas such as Global Finance Systems and Human Capital Management, which includes payroll processing, franchisee management, master data management, and legal applications [2] - Cognizant will contribute its expertise in product development, digital engineering, and quality assurance, along with innovations in Cloud, Enterprise AI, and Generative AI, aimed at enhancing staff enablement, customer experience, and operational efficiency for McDonald's [3] Strategic Initiatives - McDonald's operates in over 100 countries, focusing on sustained product innovation, geographic expansion, loyalty programs, and digital initiatives to enhance customer experience, operational improvements, service times, and customer satisfaction [4] - The company aims to improve performance in International Operated Markets, including Australia, Canada, France, Germany, and the United Kingdom, through value meals, menu customization, restaurant reimaging, efficient marketing, and increased convenience via delivery and digital presence [5] Financial Performance - McDonald's shares have increased by 11.3% over the past six months, compared to a 13.2% growth in the Zacks Retail - Restaurants industry [7] - Despite macroeconomic challenges and rising commodity and wage costs, McDonald's anticipates that its strategic initiatives will drive growth, with plans to open 50,000 restaurants by 2027 [7]